Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
![Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40265-023-01897-2/MediaObjects/40265_2023_1897_Fig1_HTML.png)
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs
![Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-023-00347-6/MediaObjects/41533_2023_347_Fig1_HTML.png)
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
![Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213219818300904-gr1.jpg)
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
![Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK499554/bin/fm.s5f1.jpg)
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
![Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease. - Abstract - Europe PMC Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6964260/bin/41030_2017_46_Fig1_HTML.jpg)
Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease. - Abstract - Europe PMC
![The new era of add-on asthma treatments: where do we stand? | Allergy, Asthma & Clinical Immunology | Full Text The new era of add-on asthma treatments: where do we stand? | Allergy, Asthma & Clinical Immunology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13223-022-00676-0/MediaObjects/13223_2022_676_Fig1_HTML.png)